Navigating the Limitations of Generative AI in Biotechnology: A 2023 Perspective

4 min readNov 20, 2023

In the evolving landscape of biotechnology and genetic engineering, the integration of artificial intelligence (AI) has marked a substantial advancement. However, despite this progress, the sector encounters several limitations that challenge the full realization of AI’s potential in genomics and CRISPR applications.

Data Integration Challenges

In biotechnology, particularly in gene therapy and bioinformatics, AI and ML are used to handle diverse and heterogeneous data sets, such as DNA microarrays and RNA-seq data. The challenge lies in integrating these varied data types in a meaningful way. Traditional methods like data normalization often fall short as they don’t provide a universal solution. Transfer learning emerges as a potential answer, enabling the use of data from different domains without combining them, thus maintaining the integrity and specificity of each data type.

Network-Based Approaches in Molecular Medicine

Network-based approaches in stem cells research and synthetic biology involve studying gene regulatory networks, which include transcription regulation, protein interactions, and metabolic networks. Each network type provides insights into molecular interactions on the cellular level. The integration of these networks is essential for a comprehensive understanding of systems biology. However, this integration is complex and requires multi-scale network studies to provide a detailed understanding of molecular organization patterns.

The Rise of Deep Learning

Deep learning, part of AI, has gained prominence since 2012, offering flexibility in building neural networks for various tasks. However, these models are often criticized as “black-box” models because they make predictions without clear explanations. This lack of transparency is particularly problematic in medical contexts, where clinical decisions based on AI analysis need to be understandable to patients. The challenge is to enhance the interpretability of these models without compromising their predictive power.

Biomarkers and Genetic Testing

Biomarkers are used in diagnostics and therapy but have limitations. For example, prognostic signatures in breast cancer make sensible predictions but do not offer insights into the causal mechanisms of the disease. This means they have predictive utility in clinical practice but limited biological utility in understanding the disease at a molecular level. This limitation raises questions about the overall effectiveness of biomarkers in revealing the molecular functioning of biological processes.

Statistical Considerations and Robustness

AI and ML in molecular medicine still require a solid foundation in statistical analysis. This includes ensuring the reproducibility of studies, multiple testing corrections, and regularization of regression models. These statistical considerations are crucial for the robustness and biological significance of findings in molecular medicine. The challenge lies in incorporating these statistical approaches effectively within the AI and ML frameworks.

Genotype to Phenotype Connections in Agricultural Biotechnology

In areas like agricultural biotechnology, experts seek to understand the relationship between genotype and phenotype. This requires bridging from genotype to phenotype, a complex task that often employs network approaches. However, further investigations are needed to merge predictive models with these network approaches. Reductionist methods tend to be insufficient in this context, indicating the need for AI and ML to address these conceptual challenges.

Discover how OctetBio can enhance your biotechnology and AI endeavors. Specializing in no-code/low-code solutions tailor-made for your business, OctetBio propels you towards the future of business agility and tech-savvy innovation. Learn more about our services at OctetBio.

Generative AI Limitations in Tissue Engineering and Proteomics

Generative AI, including large language models, faces several limitations in research. These include the generation of incorrect or fictitious information, difficulty in reproducing results consistently, and the lack of real-time data verification. These limitations are particularly problematic in academia and research, where accuracy and reproducibility are paramount.

Privacy and Data Security Concerns

Generative AI raises concerns regarding privacy and data security, especially when dealing with sensitive or identifiable information. The challenge is to maintain privacy and comply with data protection regulations while using AI tools in research and academia.

Incorporation into Existing Products

The integration of generative AI into existing products like Google Workspace and Microsoft Office introduces new challenges. Researchers and academics need to exercise caution, especially regarding the use of features like auto-completion and text generation, to ensure the integrity and originality of their work.

Generative AI Detectors and Their Limitations

The development of AI detectors to identify generative AI content has its own set of challenges. These tools can sometimes be unreliable, incorrectly flagging human-created content as AI-generated. Reliance solely on these detectors is not advisable, and alternative methods of verification should be considered.

Conclusion

The integration of generative AI into biotechnology, encompassing areas from genetic engineering to stem cell research, is transformative. Addressing its limitations in data integration, network-based approaches, and ensuring privacy are crucial for its successful application.